OV6 promotes HCC tumors and leads to increased self-renewal capacity, tumorigenicity, and invasive and metastatic properties through positive correlation with C-X-C chemokine receptor type 4 (CXCR4) and its specific ligand, CXCL12 (SDF-1) [109]. Here, CXCL12 is linked to hepatocellular carcinoma.